Newly Proposed Sepsis-Induced Coagulopathy Precedes International Society on Thrombosis and Haemostasis Overt-Disseminated Intravascular Coagulation and Predicts High Mortality
Abstract
Background:
Disseminated intravascular coagulation (DIC) has been recognized as an urgent and critical condition in patients with sepsis. Therefore, unfamiliar and time-consuming tests or a complex scoring system are not suitable for diagnosis. Sepsis-induced coagulopathy (SIC), a newly proposed category delineated by a few global coagulation tests, has been established as an early warning sign for DIC. The purpose of this study was to elucidate the characteristics of SIC, especially in relation to the score of the International Society on Thrombosis and Haemostasis (ISTH) for overt DIC.
Method:
A data set for 332 patients with sepsis who were suspected to have DIC, antithrombin activity <70%, and treated with antithrombin substitution was utilized to examine the relationship between SIC and overt DIC. The performance of SIC calculated at baseline (ie, before treatment) as well as on days 2, 4, or 7 was analyzed in terms of its ability to predict 28-day mortality and overt DIC.
Results:
At baseline, 149 (98.7%) of 151 patients with overt DIC according to the ISTH definition were diagnosed as having SIC. Of the 49, 46 (93.9%) patients who developed overt DIC between days 2 and 4 had received a prior diagnosis of SIC. The sensitivity of baseline SIC for the prediction of death was significantly higher than that of overt DIC (86.8% vs 64.5%, P < .001). The sensitivity of SIC on days 2, 4, and 7 was significantly higher than those of overt DIC (96.1%, 92.3%, and 84.4% vs 67.1%, 57.7%, and 50.0%, P < .001, .001, and .001, respectively), although the specificity of SIC was lower at all time points.
Get full access to this article
View all access and purchase options for this article.
References
1. Taylor FB, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86(5):1327–1330.
2. Ranieri VM, Thompson BT, Barie PS, et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med. 2012;366(22):2055–2064.
3. Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45(3):486–552.
4. Hayakawa M, Yamakawa K, Saito S, et al. Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study. Thromb Haemost. 2016;115(6):1157–1166.
5. Tagami T, Matsui H, Horiguchi H, Fushimi K, Yasunaga H. Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study. J Thromb Haemost. 2014;12(9):1470–1479.
6. Iba T, Thachil J. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan. Int J Hematol. 2016;103(3):253–261.
7. Iba T, Gando S, Thachil J. Anticoagulant therapy for sepsis-associated disseminated intravascular coagulation: the view from Japan. J Thromb Haemost. 2014;12(7):1010–1019.
8. Nishida O, Ogura H, Egi M, et al. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016). Acute Med Surg. 2018;5(1):3–89.
9. Umemura Y, Yamakawa K, Ogura H, Yuhara H, Fujimi S. Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials. J Thromb Haemost. 2015;14(3):518–530.
10. Yamakawa K, Umemura Y, Hayakawa M, et al. Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan. Crit Care. 2016;20(1):229.
11. Gando S, Iba T, Eguchi Y, et al. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med. 2006;34(3):625–631.
12. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–810.
13. Iba T, Di Nisio M, Thachil J, et al. Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity. Crit Care. 2016;20:287.
14. Asakura H, Takahashi H, Uchiyama T, et al. Proposal for new diagnostic criteria for DIC from the Japanese society on thrombosis and hemostasis. Thromb J. 2016;14:42.
15. Gando S, Levi M, Toh CH. Disseminated intravascular coagulation. Nat Rev Dis Prim. 2016;2:16037.
16. Hack CE. Fibrinolysis in disseminated intravascular coagulation. Semin Thromb Hemost. 2001;27(6):633–638.
17. Iba T, Di Nisio M, Thachil J, et al. A proposal of the modification of Japanese Society on Thrombosis and Hemostasis (JSTH) disseminated intravascular coagulation (DIC) diagnostic criteria for sepsis-associated DIC. Clin Appl Thromb Hemost. 2018;24(3):439–445. doi:10.1177/1076029617720069.
18. Iba T, Di Nisio M, Levy JH, Kitamura N, Thachil J. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open. 2017;7(9):e017046.
19. Levi M, Schultz MJ. What do sepsis-induced coagulation test result abnormalities mean to intensivists? Intensive Care Med. 2017;43(4):581–583.
20. Semeraro N, Ammollo CT, Semeraro F, Colucci M. Coagulopathy of acute sepsis. Semin Thromb Hemost. 2015;41(6):650–658.
21. Gando S, Saitoh D, Ogura H, et al. A multicenter, prospective validation study of the Japanese association for acute medicine disseminated intravascular coagulation scoring system in patients with severe sepsis. Crit Care. 2013;17(3):R111.
22. Ogura H, Gando S, Saitoh G, et al. Epidemiology of severe sepsis in Japanese intensive care units: a prospective multicenter study. J Infect Chemother. 2014;20(3):157–162.
23. Toh CH, Hoots WK. The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview. J Thromb Haemost. 2007;5(3):604–606.
24. Iba T. The meanings of DIC diagnostic criteria. Thromb Res. 2012;129(5):e269–e270.
25. Takemitsu T, Wada H, Hatada T, et al. Prospective evaluation of three different diagnostic criteria for disseminated intravascular coagulation. Thromb Haemost. 2011;105(1):40–44.
26. Meziani F, Gando S, Vincent JL. Should all patients with sepsis receive anticoagulation? Yes. Intensive Care Med. 2017;43(3):452–454.
27. van der Poll T, Opal SM. Should all septic patients be given systemic anticoagulation? No. Intensive Care Med. 2017;43(3):455–457.
28. Tagami T, Matsui H, Fushimi K, Yasunaga H. Supplemental dose of antithrombin use in disseminated intravascular coagulation patients after abdominal sepsis. Thromb Haemost. 2015;114(3):537–545.
29. Wada H, Thachil J, Di Nisio M, et al. Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost. 2013;11:761–767.
Cite article
Cite article
Cite article
OR
Download to reference manager
If you have citation software installed, you can download article citation data to the citation manager of your choice
Information, rights and permissions
Information
Published In
Article first published online: May 2, 2018
Issue published: July 2020
Keywords
PubMed: 29720054
Authors
Metrics and citations
Metrics
Journals metrics
This article was published in Journal of Intensive Care Medicine.
VIEW ALL JOURNAL METRICSArticle usage*
Total views and downloads: 831
*Article usage tracking started in December 2016
Articles citing this one
Receive email alerts when this article is cited
Web of Science: 43 view articles Opens in new tab
Crossref: 47
- Septic Coagulopathy: Pathophysiology, Diagnosis, and Therapeutic Strat...
- Sepsis-Induced Coagulopathy
- The prevalence of sepsis-induced coagulopathy in patients with sepsis ...
- The pathophysiology, diagnosis, and management of sepsis-associated di...
- Decoding Sepsis-Induced Disseminated Intravascular Coagulation: A Comp...
- Management of patients on antithrombotic therapy with severe infection...
- Prognostic Impact of the International Society on Thrombosis and Hemos...
- Effectiveness of early heparin therapy on outcomes in critically ill p...
- Validation of Two Revised, Simplified Criteria for Assessing Sepsis-As...
- Sepsis-Induced Coagulopathy: An Update on Pathophysiology, Biomarkers,...
- Heparin, Heparan Sulphate and Sepsis: Potential New Options for Treatm...
- Research Progress in Sepsis-Induced Disseminated Intravascular Coagula...
- Management Strategies in Septic Coagulopathy: A Review of the Current ...
- Potential Biomarkers for Early Diagnosis, Evaluation, and Prognosis of...
- Prognostic Accuracy of the Different Scoring Systems for Assessing Coa...
- Sepsis-induced Coagulopathy: The Different Prognosis in Severe Pneumon...
- Communication from the Scientific and Standardization Committee of the...
- Anticoagulant therapies against sepsis‐induced disseminated intravascu...
- Coagulation Influencing Liberation from Respiratory Support in Patient...
- Phenotype-oriented anticoagulant therapy for sepsis: still a work in p...
- The pathophysiology of sepsis — 2021 update: Part 2, organ dysfunction...
- Favorable Outcomes of Anticoagulation With Unfractioned Heparin in Sep...
- Disfunción en la plasminogénesis en paciente críticamente enfermo con ...
- An Interpretable Early Dynamic Sequential Predictor for Sepsis-Induced...
- Clinical value of pediatric sepsis‐induced coagulopathy score in diagn...
- Therapeutic strategies in patients with coagulopathy and disseminated ...
- Coagulopathy and sepsis: Pathophysiology, clinical manifestations and ...
- SOFA Score as a Reliable Tool to Detect High Risk for Venous Thrombosi...
- Plasma Endothelial Glycocalyx Components as a Potential Biomarker for ...
- Validation of sepsis-induced coagulopathy score in critically ill pati...
- Understanding COVID-19-associated coagulopathy: From PIC to SIC or DIC
- DIAGNOSTIC CRITERIA FOR DISSEMINATED INTRAVASCULAR COAGULATION SYNDROM...
- Sepsis—Pathophysiology and Therapeutic Concepts
- Development of a Nomogram to Predict 28-Day Mortality of Patients With...
- Evaluation of Sepsis-Induced Coagulopathy in Critically Ill Pediatric ...
- A Machine-Learning Approach for Dynamic Prediction of Sepsis-Induced C...
- Disseminated Intravascular Coagulation
- Recent advances in the research and management of sepsis-associated DI...
- Role of Thromboelastography as an Early Predictor of Disseminated Intr...
- The Doctors in ICU Need to Know the Basics of Coagulopathy
- A 21st Century Evil: Immunopathology and New Therapies of COVID-19
- Haematological characteristics and risk factors in the classification ...
- Is there a rationale for heparin use among severe COVID-19 patients?
- The Value of Thromboelastography in the Diagnosis of Sepsis-Induced Co...
- New criteria for sepsis-induced coagulopathy. Review
- Diagnosis of sepsis‐induced disseminated intravascular coagulation and...
- Advance in the Management of Sepsis-Induced Coagulopathy and Dissemina...
Figures and tables
Figures & Media
Tables
View Options
Get access
Access options
If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:
loading institutional access options
Alternatively, view purchase options below:
Purchase 24 hour online access to view and download content.
Access journal content via a DeepDyve subscription or find out more about this option.
